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Perspective
Introduction
Extracorporeal membrane oxygenation (ECMO) is a 
lifesaving tool and substantial part of every mechanical 
circulatory support program. There are substantial 
differences in ECMO in pediatric patients compared to 
adults, including indications, setup of the ECMO circuit, as 
well as implantation sites. The Extracorporeal Life Support 
Organization (ELSO) represents the largest database 
worldwide and produces regular reports on international 
growth, outcomes, complications, and technology used in 
ECMO. Traditionally, there is one annual report focusing 
on adults and another one on pediatrics. The latest ELSO 
report showed that 71% of all ECMO implants were done 
in children, and neonates represented 47% of the whole 
cohort (1). There are almost 60,000 children receiving ECMO 
support who have been reported to the ELSO registry. 
Recent advances in ECMO have led to increasing interest 
in its use during cardiopulmonary resuscitation (CPR). 
However, decisions regarding extracorporeal CPR (eCPR) 
in children are difficult because of the current paucity of 
robust data. This article aims to provide a short overview of 
indications for ECMO in the pediatric population, highlight 
differences between pediatric and adult ECMO, and share 
our own results, with a focus on eCPR. 
Indications
Traditionally, pediatric ECMOs were used in congenital 
heart surgery when weaning from cardiopulmonary bypass 
(CPB) was not possible (post-cardiotomy ECMO). Due to 
favorable results (1), the indications have been extended 
to provide therapy to patients with cardiogenic shock 
requiring massive inotropic support, and finally for out 
of hospital cardiac arrest scenarios (2). For all of these 
indications, a cardiopulmonary support in the form of veno-
arterial (VA) ECMO is required. The ability of VA ECMO 
to provide cardiac and respiratory support differs from the 
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isolated oxygenation-ventilation support provided by veno-
venous (VV) ECMO. To qualify for VV ECMO support, 
the cardiac pump function must be adequate to maintain 
pulmonary and systemic perfusion. When possible, 
echocardiography is performed to assess systolic ventricular 
function to aid decision-making. 
The most common indications for ECMO implantations 
are listed in Table 1. The list of contraindications for ECMO 
in children is shrinking, with absolute contraindications 
including lethal chromosomal or syndromic abnormalities, 
and severe, irreversible brain or multiorgan injury. 
ECMO circuit and implantation technique
In the pediatric ECMO population, we face a wide range 
of weights and dimensions ranging from 4.25 to 60 kg. 
Therefore, different ECMO circuits and cannulas catering to 
these weight categories are used. As previously published (3), 
we use a Thoratec Centrimag® or PediVas® (Levitronix, 
Zurich, Switzerland) console with a back-up unit, heater 
unit, and a Sechrist Air-Oxygen-Mixer (Sechrist Industries, 
Anaheim, USA). For neonates and infants weighing up to 
15 kg, the whole circuit contains approximately 250 mL 
priming volume with flow ranges up to 1.7 L/min; for 
children above 15 kg, the volume of priming solution is 
about 750 mL, with a capacity of achieving flow rates up 
to 7.0 L/min, which can also sufficiently cater to adult 
patients. Likewise, implantation sites differ. In adults, and 
in an emergency setting like cardiac arrest, femoral access 
is mainly used. In children, especially before the walking 
age, as a rule, the femoral vessels are not developed well 
enough to be suitable for ECMO cannulation and support. 
Cannulation for neonates, infants and small children 
focuses on either the neck vessels or large central vessels via 
median sternotomy. Neck cannulation has the advantage of 
being an expeditious procedure in an emergency situation, 
even during mechanical CPR, without causing major 
interruption to chest compressions. On the other hand, 
higher flow rates on ECMO might be able to be achieved 
when using the ascending aorta and the right atrium as 
cannulation sites. Theoretically, neck cannulation may carry 
the risk of blocking antegrade flow to the RCA, which in 
the setting of CPR, cerebral ischaemia or an incomplete 
circle of Willis, may increase the risk of ischaemic or 
haemorrhagic stroke. However, there is no clear evidence 
in the literature for this assumption (4). For VV ECMO 
implantations, our primary cannulation strategy is the 
internal jugular vein using the Avalon cannula (AVALON®, 
Avalon Laboratories, LLC, California, USA). We have 
performed both surgical cut down to the vessel, as well as 
cannulation using the Seldinger technique for implantation. 
Implantation is guided by either echocardiographic or X-ray 
imaging to ensure adequate orientation of the cannula 
ports. Their proper position must be confirmed with 
echocardiography, especially the location of the outflow 
lumen, which must be positioned in the center of the right 
atrium with the flow directed towards the tricuspid valve. 
More “traditional” implantation sites combine the jugular 
vein and femoral vein. Advantages of a dual-lumen cannula 
using a single implantation site include a decrease in blood 
recirculation, easier patient mobilization, and lower risk of 
dislodgment (5). 
Different combinations of the implantation sites are 
possible (i.e., internal carotid artery and right atrium), but 
other sites may also be used in older children, such as the 
subclavian artery and femoral vessels as in adults. 
ECMO in the setting of cardiac arrest
Patients in cardiac arrest refractory to CPR may be placed 
on ECMO (commonly known as eCPR). The application 
of eCPR seems to provide superior cerebral perfusion 
compared to external compressions (6,7). The reported 
incidence of cardiac arrest after cardiac surgery varies 
between 0.7–8% (8). ECPR remains an integral part of 
every “state of the art” congenital cardiac surgery program. 
As per published guidelines, it is recommended that 
post-cardiotomy patients should undergo re-sternotomy 
within 5 minutes of cardiac arrest (9). If no reversible 
cause of cardiac arrest such as pericardial tamponade is 
found, ECMO implantation should be performed. In 
cardiac arrest scenarios with in- or out-of-hospital CPR, 
all efforts must be made to minimize the time to ECMO 
implantation. There is inadequate clarity regarding criteria 
such as duration to ECMO, lowest pH, highest lactate and 
time taken for pH to normalize in relation to clinical and 
neurological outcomes, which would guide us in optimizing 
use of this critical resource intensive therapy. The decision 
as to whether eCPR is provided or not is mainly based on 
institutional algorithms (10).
Nevertheless, CPR duration >30 minutes was reported 
to be a significant risk factor for death (11). According to 
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the latest pediatric ELSO report, the majority of children 
(73%) received CPR for less than 60 min before ECMO 
support (12). Regular staff education and cardiac arrest 
simulations including check-lists which defines task 
allocation of each participant during eCPR may facilitate 
the intervention and prevent unnecessary collisions during 
CPR (10).
The use of eCPR is increasing in children (12). The 
2016 ELSO report shows that almost 11% of all ECMO 
implantations are done in the setting of cardiac arrest (1). 
Thirteen percent of all pediatric ECMO cases are 
initiated in cardiac arrest scenarios, with the highest 
percentage being neonates (36% of all neonatal ECMO 
implantations) (1). While eCPR is typically performed 
via the femoral vessels in adults, this is not a valid option 
in children and neonates. As previously discussed, neck 
cannulation in pediatric patients has the advantage of 
allowing uninterrupted chest compressions during ECMO 
implantation, whereas during central cannulation, chest 
compressions must be interrupted for surgical placement. 
As outlined above, however, an important issue to consider 
with neck cannulation in children is that a sufficient cerebral 
perfusion depends on a functioning circle of Willis. Some 
centers ligate the distal internal carotid artery to protect 
from thromboembolism and subsequent cerebral infarction; 
others do not and reconstruct the internal carotid artery 
after cannula explantation. Long-term neurologic outcome 
in pediatrics after ECMO remains a matter of research.
Table 1 Common indications for ECMO in pediatrics
Indications Neonate Pediatric
Cardiac Congenital defect: 
 Hypoplastic left heart syndrome; 
 Left ventricular outflow obstruction; 
 Right ventricular outflow obstruction; 
 Septal defects
Congenital defect: 
 Left ventricular outflow obstruction; 
 Right ventricular outflow obstruction; 
 Septal defects
Cardiomyopathy (bridge to recovery, transplant or long-
term MCS)
Cardiomyopathy (bridge to recovery, transplant or long-
term MCS)
Myocarditis Myocarditis
Respiratory Meconium aspiration syndrome Pneumonia (viral/bacterial/aspiration)
Persistent pulmonary hypertension of newborn/persistent 
fetal circulation
Acute respiratory distress syndrome
Respiratory distress syndrome
Congenital diaphragmatic hernia
Pneumonia (viral/bacterial/aspiration)
Sepsis
Other indications 
at any age
Transplantation: 
 Pre-transplantation as bridge to Tx; 
 Primary graft dysfunction after heart or lung Tx
Elective periprocedural support: 
 During lung transplantation or tracheal surgery
Cardiac arrest from any cause: 
 Bridge to decision; 
 Underlying treatable disease
Air leak syndrome
Failure to wean from CPB
ECMO, extracorporeal membrane oxygenation; MCS, mechanical circulatory support; Tx, transplant; CPB, cardiopulmonary bypass.
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When central cannulation is performed, both internal 
carotid arteries remain perfused. Another advantage of 
central cannulation lies in the access and size of the target 
vessels. It can be presumed that central cannulation helps 
achieve higher flow rates as it enables the implantation of 
larger diameter cannulae.
Survival to discharge after eCPR varies between 29% 
to 43%, depending on age group and whether in- or out-
of-hospital CPR was performed (1,2,12,13). Prematurity 
represents an important risk factor in both non-CPR 
ECMO and eCPR scenarios (14). Data from the ELSO 
registry indicates that the overall survival rate to discharge 
for premature infants (<37 weeks gestation) who received 
cardiac extracorporeal life support (ECLS) was 31%, 
compared to 41% in term infants (1). Similarly, while 
the reported survival in pre-term babies following eCPR 
has approached 30%, it can be as low as 21% in neonates 
<34 weeks gestational age.
Own demographic data 
Over the past years, we have observed a substantial increase 
in the number of ECMO implantations (see Figure 1). 
While there were 0.25 to 1.1 implants per month between 
2005 and 2013, we saw a significant increase of up to four 
implants per month in 2018 (see Figure 2). Since 2014, our 
team at the children’ hospital in Zurich has performed 92 
ECMOs implantations in 34 neonates and 58 pediatric 
patients (see Table 2). The majority (80%) were (VA) ECMO 
placements, while 20% were VV implants (Table 3). The 
primary cannulation strategy for all ECMO placements is 
shown in Table 4. Sternotomy with central cannulation was 
used in 54% of patients, followed by neck cannulation (42%) 
and others (3%). All VV ECMO were inserted via the 
internal jugular vein using the Avalon cannula (AVALON®, 
Avalon Laboratories, LLC, California, USA). Surgical cut-
down was performed in 15 cases, whereas in three cases the 
jugular vein was punctured using a Seldinger technique. 
The smallest child receiving VV ECMO support using 
Avalon cannula was 50 days old and weighted 4.2 kilograms. 
Out of 92 implants, 29 placements (32%) have been 
performed in the setting of cardiac arrest. All eCPR 
implants were VA ECMO with either neck (n=8) or central 
cannulation (n=21) (Table 3). Eleven implants have been 
done in the operating theatre (OR), whereas the majority 
(90%) has been installed outside the OR. Survival to 
discharge out of hospital was 28%, with a higher likelihood 
in the pediatric group (0.35 per patient) compared to 
neonates (0.1 per patient) (Table 5). For this report, we 
did not investigate differences between in-hospital CPR 
and out-of-hospital CPR, which is a known risk factor for 
outcome (2). 
Long-term outcome
Most of the reports reviewed have focused on outcomes 
until hospital discharge or transfer. Long-term outcome and 
further development are not well reported, for a number 
of reasons. First, it is clear that the outcome depends on 
the underlying disease and indication for ECMO. While 
children recovering from respiratory failure or sepsis might 
have a normal life expectancy, children suffering from 
complex congenital heart disease might require many re-do 
surgeries and a limited life expectancy. In The Netherlands, 
Hanekamp and colleagues evaluated national wide newborns 
Figure 1 Absolute numbers of ECMO implantations at our 
unit. *, until 1st of July 2018. ECMO, extracorporeal membrane 
oxygenation. 
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Figure 2 The distinct rise of ECMO implantations per month 
at our unit. *, until 1st of July 2018. ECMO, extracorporeal 
membrane oxygenation.
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treated with ECMO at 5 years of age and focused on 
cognitive, neuromotor, and neuropsychological outcomes. A 
small percentage (6%) suffered major neurodevelopmental 
disability, but overall mean cognitive development did 
not differ significantly from the control group (15). More 
research is necessary to address the long-term neurological 
outcome in children receiving ECMO stratified by variables 
including indications, type of cannulation, type of ECMO 
and duration of CPR.
Comments
Traditionally, ECMO has a high value in pediatrics and 
neonates, and implantation numbers have been increasing 
over the past few decades. ECMO can be used in many 
settings to support pediatric patients with cardiac, respiratory, 
and other indications. In light of the growing applications 
of ECMO, however, a detailed analysis of outcomes is 
Table 2 Patients <18 years of age needing ECMO support stratified by age and indication 
Indications Total cases
Survival to discharge or transfer
N %
Neonates (<30 days)
Total 34 10 29.4
Respiratory 3 1 33.3
Cardiac 31 9 29.0
eCPR 9 2 22.2
Pediatric
Total 58 30 51.7
Respiratory 20 16 80
Cardiac 38 14 36.8
eCPR 20 7 35
ECMO, extracorporeal membrane oxygenation; eCPR, extracorporeal cardiopulmonary resuscitation.
Table 3 ECMO strategies in patients <18 years of age needing 
ECMO support 
ECMO strategies Implantation, N 
ECMO (overall) 92
VV ECMO* 18 
VA ECMO* 74 
ECMO under CPR (eCPR) 29 
*, until 1st of July 2018. ECMO, extracorporeal membrane 
oxygenation; VV, veno-venous; VA, veno-arterial; CPR, cardio 
pulmonary resuscitation; eCPR, extracorporeal CPR.
Table 4 Cannulation strategy for ECMO placement in patients 
<18 years
Cannulation strategy Implantation, N
Neck cannulation
VA 21
VV 18
Chest cannulation
VA 50
VV 0
Other
VA 3
VV 0
Cannulation in eCPR*
Neck 8
Chest 21
*, until 1st of July 2018. ECMO, extracorporeal membrane 
oxygenation; VV, veno-venous; VA, veno-arterial; eCPR, 
extracorporeal cardiopulmonary resuscitation.
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becoming increasingly important to ensure that this resource-
intensive therapy remains available for appropriate candidates 
and facilitates favorable long-term survival and functional 
prognosis. In particular, greater research is required to 
investigate long-term neurodevelopmental outcomes in 
surviving pediatric ECMO patients.
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